Significant Changes in HPLC System Suitability: New USP Provisions Planned

Recommendation
13-15 May 2025
Vienna, Austria
Practical Approaches for USP General Chapter <1058> Compliance in the QC Laboratory
A revision of General Chapter <621> on Chromatography is proposed in the Pharmacopeial Forum (volume 38, edition 2). This new chapter has a major impact on system suitability tests (SST).
In the current USP 35, adjustments in the mobile phase in gradient conditions are not recommended. Now, adjustments should be possible but as they may cause changes in selectivity, they should be made with caution.
The revised USP chapter now defines for each variable of the SST whether this variable applies for isocratic separations only or for gradient separations, too. In the future, the following parameters of the SST will be possible for gradient separations:
- pH of the mobile phase (+/-0,2)
- Concentration of salts in buffer (+/- 10 %)
- Injection volumes
- Column temperature (+/-10%)
Different length, internal diameter, and/or particle size in the stationary phase in gradient separations are not allowed.
Also the formula for calculating the flow rate will be modified. A new table will also be created to show the interaction between the variables length, internal diameter, particle size, and flow rates for a few significant column configurations. The objective of this is to maintain the performance of the separation system when modifying the SST parameter.
On the contrary, changes in the chemical characteristics of the stationary phase will be considered a modification to the method and will require full validation.
Comments to the draft of the new USP chapter on Chromatography can be sent until 31 May 2012.
The requirements laid down in pharmacopoeias regarding system suitability tests and their practical implementation will be one of the key topics of ECA's Education Course "Maximising HPLC Productivity" taking place from 18 - 20 April 2012 in Prague, Czech Republic.
Please also visit the USP/PF webpage for further information.
Author:
Günter Brendelberger
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
23.04.2025OTC Drug Production Ceased after FDA Warning Letter
23.04.2025EMA publishes Draft of ICH M13B Guideline on Bioequivalence
16.04.2025EMA publishes four new product-specific Bioequivalence Guidance
09.04.2025Missing Tests and Altered Records: FDA Warns Chinese OTC Manufacturer
09.04.2025Pharmeuropa: New Chapter on Evaporative Light-Scattering Detection published for Comment
09.04.2025Pharmeuropa: Four Draft Chapters on Elemental Analysis Published for Comment